PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM ExpressionKim H.T. Paraiso, Keiran S.M. Smalley|Cancer Research|2011Cited by 546
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapyKim H.T. Paraiso, Keiran S.M. Smalley|British Journal of Cancer|2010Cited by 313
Dysregulation of Claudin-7 Leads to Loss of E-Cadherin Expression and the Increased Invasion of Esophageal Squamous Cell Carcinoma CellsMercedes Lioni, Keiran S.M. Smalley|American Journal Of Pathology|2007Cited by 134
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levelsKeiran S.M. Smalley, Meenhard Herlyn|British Journal of Cancer|2007Cited by 105
Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 OverexpressionKeiran S.M. Smalley, Katherine L. Nathanson|Cancer Research|2008Cited by 97